Endpoints News ٨ أبريل ٢٠٢٦ Merck adjusts its vaccine supply deal in China; Soleno withdraws EU application
Endpoints News ٧ أبريل ٢٠٢٦ Terns sold to Merck for 13% lower than pharma's initial offer because of clinical data
Endpoints News ٢٥ مارس ٢٠٢٦ Merck to buy Terns for $6.7B, taking a leukemia drug that could challenge Novartis' Scemblix
Endpoints News ٢٤ مارس ٢٠٢٦ Merck partners with Flagship startup Quotient to search for genetic clues to IBD
Endpoints News ١٨ ديسمبر ٢٠٢٥ Daiichi and Merck's I-Dxd lung cancer study faces partial hold due to deaths
Endpoints News ٥ ديسمبر ٢٠٢٥ German court stops Merck from selling subcutaneous Keytruda in patent battle with Halozyme